Clinical Trial

Phase I Clinical Trial of YKYY031 for Injection in Patients With Advanced Solid Tumors

Study acronym: YKYY031,tumors
Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
Phase I study of YKYY031 for injection in patients with advanced solid tumors
Trial Details
NCT Number NCT07631793
Lead Sponsor Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.
Conditions Malignant Neoplasms
Enrollment 76 participants
Start Date 2026-05-30
Primary Completion 2027-12-08 (estimated)
Study Completion 2030-12-07 (estimated)
Updated on ClinicalTrials.gov 2026-06-08